Mike Ragno is Business Development Manager– Drug Discovery and Preclinical CRO As an executive recruiter, how do you feel the needs of the CROs differ from other areas of the Life Science industry?   In dealing with CROs almost exclusively…

The havoc that ensued once Sprint and Nextel’s merger was finalized back in 2004 is among the most impressive failures in recent merger and acquisition history. Although the New York Times cited the merger as the creation of a “Cellphone…

Looking at recent market trends, it’s clear that certain stages of drug development can be outsourced to help reduce spending costs, while also fueling drug discovery. The CRO market is heavily concentrated in North America, and pharma and biotech companies…

The pharmaceutical industry is used to moving targets. With frequent regulatory changes, updates to patient rights, and the continuously shifting healthcare landscape, understanding how the industry is shifting requires full-time assessment.  For those looking for new roles within the industry,…

Mergers and acquisitions – M&A for short – are a common occurrence in big business. The pharmaceuticals and biotech industries are no strangers to strategic growth and contraction when money is on the line. As an employee in one of…

Leadership trainers and executive coaches generally agree…controlling the trajectory of your career requires your attention. Oh sure, they will say your career will “happen” with or without your personal attention. It won’t stand still, and neither will you. But, circumstances…

As one of the country’s major pharmaceutical industry recruiters, Key Corporate Services follows the trends in that industry closely.  A recent article in Chemical & Engineering News highlighted some very positive 2015 trends in the pharma sector. The most significant…